Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers

Diabetes

Volumn 46, Issue 11, 1997, Pages 1701-1710

  Bingley, Polly J ^a,d   Bonifacio, Ezio ^c   Williams, Alistair J K ^a   Genovese, Stefano ^c   Bottazzo, Gian Franco ^b   Gale, Edwin A M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ENZYME ANTIBODY; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD;

EID: 0030695027     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.11.1701     Document Type: Article

References (31)

1. Bonifacio E, Bingley PJ, Dean BM, Shattock M, Dunger D, Gale EAM, Bottazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147-149, 1990
2. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein J, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, Rotter JI: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323:1167-1172, 1990
3. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EAM: Combined analysis of autoantibodies improves pre diction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310, 1994
4. Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS: Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type 1 diabetes. Diabetes 38:1320-1325, 1989
5. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
6. Schatz D, Krischer J, Horne G, Riley W, Spillar R, Silverstein J, Winter W, Muir A, Derovanesian D, Shah S, Malone J, Maclaren N: Islet cell antibodies predict insulin dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 93:2403-2407, 1994
7. Bruining GJ, Molenaar JL, Grobbee DE, Hofman A, Scheffer GJ, Bruining HA, de Bruyn AM, Valkenburg HA; Ten-year follow-up study of islet cell antibodies and childhood diabetes mellitus. Lancet i:1100-1103, 1989
8. Bingley PJ, Bonifacio E, Shattock M, Gillmor HA, Sawtell PA, Dunger DB, Scott RDM, Bottazzo GF, Gale EAM: Can islet cell antibodies predict IDDM in the general population? Diabetes Care 16:45-50, 1993
9. Levy-Marchal C, Tichet J, Fajardy I, Gu XF, Dubois F, Czernichow P: Islet cell antibodies in normal French schoolchildren. Diabetologia 35:577-582, 1992
10. Karjalainen J: Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease. Diabetes 39:1144-1150, 1990
11. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark A: Glutamate decarboxylase, insulin, and islet cell antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505-1511, 1995
12. Bingley PJ, Bonifacio E, Gale EAM: Can we really predict IDDM? Diabetes 42:213-220, 1993
13. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E: Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426, 1995
14. Bingley PJ, Gale EAM: The incidence of insulin-dependent diabetes in England: a study in the Oxford region 1985-6. Brit Med J 298:558-560, 1989
15. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale EAM, Bosi E: Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38:816-822, 1995
16. Payton MA, Hawkes CJ, Christie MR: Relationship of the 37,000- and the 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96:1506-1511, 1995
17. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen BK, Dyrberg T: Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459-467, 1994
18. Schmidli R, Colman PG, Bonifacio E: Disease sensitivity and specificity of fifty-two assays for glutamic acid decarboxylase antibodies: the second international GADAb workshop. Diabetes 44:636-640, 1995
19. Williams AJK, Bingley PJ, Bonifacio E, Palmer JP, Gale EAM: A novel microassay for insulin autoantibodies. J Autoimmunity 10:473-478, 1997
20. Zweig M, Campbell G: Receiver-operating characteristics (ROC) plots: a fundamental tool in clinical medicine. Clin Chem 39:561-567, 1995
21. Miettinen O: Estimability and estimation in case-referent studies. Am J Epidemiol 103:226-235, 1976
22. Ziegler AG, Hillebrand B, Rabl W, Mayrhofer M, Hummel M, Mollenhauer U, Vordemann J, Lenz A, Standl E: On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth. Diabetologia 36:402-408, 1993
23. Leslie RDG, Elliott RB: Early environmental events as a cause of IDDM (evidence and implications). Diabetes 43:843-850, 1994
24. Verge CF, Howard NJ, Rowley MJ, Mackay IR, Zimmet PZ, Egan M, Hulinska H, Hulinsky I, Silvestrini RA, Kamathm S, Sharp A, Arundel T, Silink M: Antiglutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 37:1113-1120, 1994
25. Aanstoot HJ, Sigurdsson E, Jaffe M, Shi Y, Christgau S, Grobbee D, Bruining GJ, Molenaar JL, Hofman A, Baekkeskov S: Value of antibodies to GAD65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia 37:917-924, 1994
26. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A: A novel radioligand binding assay to determine diagnostic accuracy of iso-form specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350, 1994
27. Genovese S, Bonifacio E, Dean BM, McNally JM, Wagner R, Bosi E, Gale EAM, Bottazzo GF: Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:385-388, 1992
28. Myers MA, Rabin DU, Rowley MJ: Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 44:1290-1295, 1995
29. Kawasaki E, Yu L, Gianani R, Verge CF, Babu S, Bonifacio E, Eisenbarth GS: Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA 512/IA-2 constructs. J Clin Endocrinol Metab 82:375-380, 1997
30. Roll U, Christie MR, Fuchtensbusch M, Payton MA, Hawkes CJ, Ziegler AG: Perinatal autoimmunity in offspring of diabetic parents: the German Multicenter BABY-DIAB Study: detection of humoral immune responses to islet autoantigens in early childhood. Diabetes 45:967-973, 1996
31. Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, Hoffman M, McDuffie RS, Hamman RF, Klingensmith GJ, Eisenbarth GS, Erlich HA: Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 39:807-812, 1996